Tumor markers in breast cancer - Evaluation of their clinical usefulness;Tumorski markeri raka dojke - Procjena njihove kliničke primjene

Collegium Antropologicum

Volumn 35, Issue 1, 2011, Pages 241-247

  Marić, Petra ^a   Ozretić, Petar ^b   Levanat, Sonja ^b   Orešković, Slavko ^a   Antunac, Katarina ^a   Beketić Orešković, Lidija ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Breast cancer; Clinical application; Genetic tumor markers; Serum tumor markers; Tissue tumor markers

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

BIOSYNTHESIS; BLOOD; BREAST TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM; REVIEW;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 79954427170     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, THUN MJ, CA Cancer J Clin, 59 (2009) 225.
2. J. FERLAY, F. BRAY, P. PISANI AND D. M. PARKIN, GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5. version 2. 0, IARC Press, Lyon, 2004.
3. AMERICAN CANCER SOCIETY, Breast Cancer Facts & Figures 2009-2010, accessed 08. 02. 2010. Available from: URL: http://www. cancer. org/acs/groups/content/@nho/documents/document/f861009final90809pdf. pdf
4. JEMAL A, TIWARI RC, MURRAY T, GHAFOOR A, SAMUELS A, WARD E, CA Cancer J Clin, 53 (2003) 4.
5. EUROPEAN GROUP ON TUMOR MARKERS, Tumour markers in breast cancer-EGTM recommendations, accessed 08. 02. 2010. Available from: URL: http://www. egtm. eu/tumour_markers_in_breast_cancer. htm
6. HARRIS J, MORROW M, NORTON L, Malignant tumors of the breast. In: DEVITA JR VT, HELLMAN S, ROSENBERG SA (Eds) Cancer: Principles and Practice of Oncology (Lippincott-Raven, Philadelphia, 1997).
7. SWENSON LI, Progress in tumor marker research. In: LUMACHI F, BASSO SMM (Eds) Serum tumor markers in breast cancer (Nova Science Publisher, 2007).
8. LUMACHI F, ERMANI M, BRANDES AA, BASSO SMM, BASSO U, BOCCAGNI P, Anticancer Res, 21 (2001) 4105.
9. DUFFY M, Clin Chem, 52 (2006) 345.
10. BARTSCH R, WENZEL C, PLUSCHNIG U, HUSSIAN D, SEVELDA U, ALTORJAI G, LOCKER GJ, MADER M, ZIELINSKI CC, STEGER GG, BMC Cancer, 6 (2006) 81.
11. MOLINA R, BARAK V, VAN DALEN A, DUFFY MJ, EINARSSON R, GION M, GOIKE H, LAMERZ R, NAP M, SOLETORMOS G, STIEBER P Tumor Biol, 26 (2005) 281.
12. SEREGNI E, COLI A, MAZZUCCA N, Eur J Nucl Med Mol Imaging, 31 (2004) 15.
13. VON MENSDORFF-POUILLY S, SNIJDEWINT FGM, VERSTRAETEN AA, VERHEIJEN RHM, KENEMANS P, Int J Biol Markers, 15 (2000) 343.
14. QUIN RJ, MCGUCKIN MA, Int J Cancer, 87 (2000) 499.
15. SCHROEDER JA, THOMPSON MC, GARDNER MM, GENDLER SJ, J Biol Chem, 276 (2001) 13057.
16. LI Y, KUWAHARA H, REN J, WEN G AND KUFE D, J Biol Chem, 276 (2001) 6061.
17. YIN L, LI Y, REN J, KUWAHARA H, KUFE D, J Biol Chem, 278 (2003) 35458.
18. CHEUNG KL, GRAVES CRL, ROBERTSON JFR, Cancer Treat Rev, 26 (2000) 91.
19. BERLING B, KOLBINGER F, GRUNERT F, THOMPSON JA, BROMBACHER F, BUCHEGGER F, VON KLEIST S, ZIMMERMANN W, Cancer Res, 50 (1990) 6534.
20. BENCHIMOL S, FUKS A, JOTHY S, BEAUCHEMIN N, SHIROTA K, STANNER C, Cell, 57 (1989) 327.
21. STEINER PM, ROOP DR, Annu Rev Biochem, 57 (1988) 593.
22. NAGLE R, Am J Surg Pathol, 12 (1988) 4.
23. MOLL R, Int J Biol Markers, 9 (1994) 63.
24. BODENMULLER H, DONIE F, KAUFMANN M, BANAUCH D, Int J Biol Markers, 9 (1994) 70.
25. SUNDRSTROM BE, STIGBRAND TI, Int J Biol Markers, 9 (1994) 102.
26. LUMACHI F, ERMANI M, BRANDES AA, BOCCAGNI P, POLISTINA F, BASSO SM, FAVIA G, D'AMICO DF, Biomed Pharmacother, 56 (2002) 88.
27. GION M, MIONE R, LEON AE, LÜFTNER D, MOLINA R, POSSINGER K, ROBERTSON JF, Eur J Cancer, 37 (2001) 355.
28. DUFFY MJ, SHERING S, SHERRY F, MCDERMOTT E, O'HIGGINS N, Int J Biol Marker, 15 (2000) 330.
29. EBELING FG, STIEBER P, UNTCH M, NAGEL D; KONECNY G E, SCHMITT U M, FATEH-MOGHADAM A, SEIDEL D, Br J Cancer, 86 (2002) 1217.
30. MOLINA R, AUGÉ JM, ESCUDERO JM, FILELLA X, ZANON G, PAHISA J, FARRUS B, MUÑOZ M, VELASCO M, Tumor Biol, 31 (2010) 171.
31. KUMPULAINEN EJ, KESKIKURU R, JOHANSSON RT, Breast Cancer Res Treat, 76 (2002) 95.
32. DUFFY MJ, DUGGAN C, KEANE R, HILL ADK, MCDERMORR E, CROWN J, O'HIGGINS N, Clin Chem, 50 (2004) 559.
33. MOLINA R, FILELLA X, ALICARTE J, ZANON G, PAHISA J, MUNOZ M, FARRUS B, BALLESTA AM, Anticancer Res, 23 (2003) 1035.
34. BAST RC, RAVDIN P HAYES DF, BATES S, FRITSCHE H, JESSUP JM, KEMENY N, LOCKER GY, MENNEL RG, SOMERFIELD, J Clin Oncol, 19 (2001) 1865.
35. FLEISHER M, DNISTRIAN AM, STURGEON CM, LAMERZ R, WITTLIFF J, Practice guidelines and recommendations for use of tumor markers in the clinic. In: DIAMINDIS EP FRITSCHE H, SCHARWTZ MK, CHAN DW (Eds) Tumor markers, physiology, pathobiology, technology and clinical applications (AACC Press, Chicago, 2002).
36. CARNEY WP, NEUMAN R, LIPTON A, PRICE C, Clin Chem, 49 (2003) 1579.
37. PEROU CM, SØRLIE T, EISEN MB, VAN DE RIJN M, JEFFREY SS, REES CA, POLLACK JR, ROSS DT, JOHNSEN H, AKSLEN LA, FLUGE O, PERGAMENSCHIKOV A, WILLIAMS C, ZHU SX, LØNNING PE, BØRRESEN-DALE AL, BROWN PO, BOTSTEIN D, Nature, 406 (2000) 747.
38. GOSS PE, The rise and current status of aromatase inhibitors in breast cancer treatment. In: Proceedings: (27th Annual San Antonio Breast Cancer Symposium, San Antonio, 2004)
39. SUROWIAK P, PALUCHOWSKI P, WYSOCKA T, WOJNAR A, ZABEL M, Pathol Oncol Res, 10 (2004) 207.
40. HALL JM, COUSE JF, KORACH KS, Biol Chem, 276 (2001) 36869.
41. JENSEN EV, JORDAN VC, Clin Cancer Res, 9 (2003) 1980.
42. WEIHUA Z, ANDERSSON S, CHENG G, SIMPSON ER, WARNER M, GUSTAFSSON JA, FEBS Lett, 546 (2003) 17.
43. CONNEELY OM, LYDON JP Steroids, 65 (2000) 571.
44. DUFFY MJ, Clin Chem, 51 (2005) 494.
45. ISAACS C, STEARNS V, HAYES DF, Semin Oncol, 28 (2001) 53.
46. VAN DE VIJVER MJ, NUSSE R, Biochim Biophys Acta, 1072 (1991) 33.
47. OLAYIOYE MA, NEVE RM, LANE HA, HYNES NE, EMBO J, 19 (2000) 3159.
48. WOLFF AC, HAMMOND ME, SCHWARTZ JN, HAGERTY KL, ALLRED DC, COTE RJ, DOWSETT M, FITZGIBBONS PL, HANNA WM, LANGER A, MCSHANE LM, PAIK S, PEGRAM MD, PEREZ EA, PRESS MF, RHODES A, STURGEON C, TAUBE SE, TUBBS R, VANCE GH, VIJVER M, WHEELER TM, HAYES DF, J Clin Oncol, 25 (2007) 1.
49. HANNA VVM, KWOK K, Mod Pathol, 19 (2006) 481.
50. HENRY LN, HAYES DF, Oncologist, 11 (2006) 541.
51. YAMAUCHI H, STEARNS V, HAYES DF, Breast Cancer, 8 (2001) 171.
52. ROSS JS, FLETCHER JA, LINETTE GP, STEC J, CLARK E, AYERS M, SYMMANS WF, PUSZTAI L, BLOOM KJ, Oncologist, 8 (2003) 307.
53. DUFFY MJ, Clin Chem, 48 (2002) 1194.
54. LUMACHI F, BASSO SMM, Thyroid, 12 (2002) 27.
55. HARRIS L, FRITSCHE H, MENNEL R, NORTON L, RAVDIN P, TAUBE S, SOMERFIELD MR, HAYES DF, BAST JR RC, J Clin Oncol, 25 (2007) 5287.
56. PAIK S, SHAK S, TANG G, KIM C, BAKER J, CRONIN M, BAEHNER FL, WALKER MG, WATSON D, PARK T, HILLER W, FISHER ER, WICKERHAM DL, BRYANT J, WOLMARK N, N Engl J Med, 351 (2004) 2817.
57. ALBAIN KS, PAIK S, VAN'T VEER L, Breast, 18 (2009) S141.
58. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNETT LM, DING W, BELL R, ROSENTHAL J, HUSSEY C, TRAN T, MCCLURE M, FRYE C, HATTIER T, PHELPS R, HAUGEN-STRANO A, KATCHER H, YAKUMO K, GHOLAMI Z, SHAFFER D, STONE S, BAYER S, WRAY C, BOGDEN R, DAYANANTH P, WARD J, TONIN P, NAROD S, BRISTOW PK, NORRIS FH, HELVERING L, MORRISON P, ROSTECK P, LAI M, BARRETT JC, LEWIS C, NEUHAUSEN S, CANNONALBRIGHT L, GOLDGAR D, WISEMAN R, KAMB A, SKOLNICK MH, Science, 266 (1994) 66.
59. VENKITARAMAN AR, Science, 286 (1999) 1100.
60. EELES RA, Breast Cancer Res, 2 (2000) 283.
61. WOOSTER R, BIGNELL G, LANCASTER J, SWIFT S, SEAL S, MANGION J, COLLINS N, GREGORY S, GUMBS C, MICKLEM G, Nature, 378 (1995) 789.
62. KING MC, MARKS JH, MANDELL JB, Science, 302 (2003) 643.
63. RATKAJ I, STAJDUHAR E, VUCINIC S, SPAVENTI S, BOSNJAK H, KRESIMIR PAVELIC K, KRALJEVIC PAVELIC S, Funct Integr Genomics, 10 (2010) 11.